TrialMolecular medicine reports2017

Cardiovascular risk assessment in osteoporotic patients using osteoprotegerin as a reliable predictive biochemical marker.

Carmen G Barbu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.